Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
942.55
3.35
(0.36%)
< Home
< Back
Zydus Lifesciences Ltd. News
>>
Zydus Lifesciences informs about press release
>>
Zydus Lifesciences gains on getting final nod for Verapamil Hydrochloride Extended Release Tablets
>>
Zydus Lifesciences gets final nod for Verapamil Hydrochloride Extended Release Tablets
>>
Zydus Lifesciences informs about investor presentation
>>
Zydus Lifesciences informs about press release
>>
Zydus Lifesciences gets USFDA’s final approval for Leuprolide Acetate injection
>>
Zydus Lifesciences gets USFDA’s final approval for Diroximel Fumarate delayed-release capsules
>>
Zydus Lifesciences gets USFDA’s tentative approval for Diroximel Fumarate delayed-release capsules
>>
Zydus Lifesciences’ Amplitude secures CE mark for robotic surgical system
>>
Zydus Lifesciences informs about press release
<<
<
6
7
8
...168
>
>>